That's Frankenstein

I'm sure she's tired of having this pointed out, but the executive director of biotechnology company Bio/Start is named Carol Frankenstein. A story quoting her is here:

"We do 25 percent of the clinical trials in the U.S. in Ohio," she said, noting that Ohio's hospitals, research institutions and its population make it an ideal environment for such study.

I wonder what kind of dark and nefarious research that would be. Let's not wait, Howard, until it's too late to find out. Gather an angry mob and pass out the torches.